Latest Headlines

Mechanisms Involved in Liver Injury: A Closer Look
Video Interview: Vinood Patel, PhD, PGCHE, fHEA, FRSC, University of Westminster, London, UK, shared valuable insight regarding chronic alcoholic demographics and biomarkers on the horizon at The International Liver Congress 2015.
Hepatitis C: Interferon's Return Stirs Controversy
The use of interferon to treat hepatitis C infections has fallen out of favor with the advent of new antivirals and drug combinations that have fewer side effects. But in a study presented at the 2015 International Liver Congress in Vienna, Austria, researchers from the UK said that physicians should put interferon back on the treatment menu.
Baclofen: Reducing Alcohol Cravings
In this video interview, Camille Barrault, MD, spoke about the implications her work with baclofen could have for the future of liver disease research at The International Liver Congress 2015, Vienna, Austria.
Liver Disease Takes Toll on the Heart
When it comes to developing heart disease, patients who have non-alcoholic steatohepatitis (NASH) liver disease are at greater risk of both cardiovascular illness and death than patients with non-alcoholic fatty liver disease a UK team reported today at the International Liver Congress in Vienna, Austria.
Inflammatory Abdominal Aortic Aneurism: Still a Quandary
For inflammatory abdominal aortic aneurysm, is open surgery or endovascular repair a better choice?
Reactivation of Hepatitis B Associated With Immunosuppressive Medications
In patients with chronic HBV, the immune system may have very low levels of the virus. When reactivation occurs due to immunosuppression, these viruses begin to replicate again. Common symptoms of this event include inflammation of the liver and elevations of liver enzyme levels in the blood. In some cases, bilirubin levels may rise in response to reactivation of infection.

Most Popular in Gastroenterology

Recent Published Journal

$vacMongoViewPlus$ $vAR$